insights_auto
Why is RGEN up 6.13%?
Dive Deeperchevron_right
RGEN:NASDAQ
Repligen Corp
$173.88
arrow_upward
+6.13%(+10.04) 1D
$173.88
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 9, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RGEN...
Open
$164.21
High
$174.82
Low
$164.21
Mkt. cap
11.04B
Avg. vol.
1.17M
Volume
1.34M
P/E ratio
237.01
52-wk high
$198.86
52-wk low
$100.99
EPS
$0.73
Beta
1.08
Shares outstanding
63.49M
No. of employees
2K
Open
$164.21
High
$174.82
Low
$164.21
Mkt. cap
11.04B
Avg. vol.
1.17M
Volume
1.34M
P/E ratio
237.01
52-wk high
$198.86
52-wk low
$100.99
EPS
$0.73
Beta
1.08
Shares outstanding
63.49M
No. of employees
2K
News stories
From web sources and news partners
Kalkine Media
·
2 days ago
Joydeep Goswami Sells 53,156 BioLife Shares Following Repligen Merger Completion
https://www.dars.gov.et/
·
2 days ago
Repligen Corporation (RGEN) Slips 2.02% to $163.84 as Bioprocessing Stock Tests Near-Term Support - SuperTrend
https://www.dars.gov.et/
·
1 week ago
RGEN Q2 2026 Earnings: EPS Beats Estimate by 18% as Shares Edge Higher - Special Dividend Alert
Profile
Repligen Corporation is an American life sciences company that develops and manufactures products used in biological drug manufacturing. The company is headquartered in Waltham, Massachusetts, and is listed on the Nasdaq under the symbol RGEN. Wikipedia
About Repligen Corp
CEOTony J. Hunt
Employees2K
Founded1981
HeadquartersWaltham, Massachusetts, United States
SectorHealth care
Websiterepligen.com